Las Vegas, United States
Digipath, Inc. is a publicly-traded Nevada corporation that specializes in cannabis data and independent testing services. Established in 1998, the company has positioned itself as a key player in the Biotechnology, Health Care, and Pharmaceutical industries. Digipath's subsidiary, Digipath Labs™, is dedicated to setting industry standards for testing all forms of cannabis-based products using FDA-compliant laboratory equipment and proprietary standard operating procedures (SOPs) to ensure product safety and efficacy.
One of the company's strengths lies in its ability to generate vast amounts of data through analytical tests. As the industry adage goes, "today's data is the key to tomorrow’s knowledge, today." Notably, Digipath, Inc. secured a $8.20M Post-IPO Equity investment on 23 July 2014. With its headquarter based in the United States, the company is well positioned to capitalize on the growing demand for reliable testing, data acquisition, and analysis in the cannabis industry.
